Lin Xichen's Form 4 filing
Structure Therapeutics Inc.GPCR · filed Jun 5, 2024
- Accession no.
- 0001415889-24-015683
- Filed
- Jun 5, 2024, 7:38 PM ET
- Trade date
- Jun 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 4 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lin XichenCIK 0001962926 | Officer (CHIEF SCIENTIFIC OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Ordinary Shares | MOption exerciseAcquired | +106,200 | $0.34 | +$36,108 | 191,907 | Direct | |
| Jun 3, 2024 | Ordinary Shares | CConversionDisposed | −106,200 | $0.00 | $0 | 85,707 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Ordinary Shares | MOption exerciseDisposed | −106,200 | $0.00 | $0 | 213,800 | Direct | |
| Jun 3, 2024 | Ordinary Shares | CConversionAcquired | +106,200 | $0.00 | $0 | 35,400 | Direct | |
| Jun 3, 2024 | Ordinary Shares | SSaleDisposed | −53,100 | $45.00 | −$796,500 | 17,700 | Direct | |
| Jun 3, 2024 | Ordinary Shares | SSaleDisposed | −53,100 | $50.00F7 | −$885,070.8 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F7
The weighted average sale price for the transaction reported was $50.004, and the range of prices were between $50.00 and $50.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Referenced by the price of 1 transaction in Table II.